Companies

via its Cytonome-ST subsidiary and Hydris cell-sorting platform, deploys more than 1,000 sorting units across 50 labs running continuously, with its patented Sexed Ultra 4M product carrying an increased 4-million viable-sperm concentration per straw that has closed the fertility gap with conventional unsexed semen.

its Orbis foam range, Europe's first flexible polyurethane foam line built around recycled post-consumer foam and mattress content, targets mattresses, bedding and furniture applications with improved circularity and reduced CO2 emissions.

the Madison, Wisconsin-based federal research center continues its position as a leading nanocellulose (CNC/CNF) R&D hub, with 2026 publications on processing methods and downstream applications for wood-fiber-derived nanoscale materials.

"Ochre" genomically recoded organism — Next-gen GRO succeeding C321.ΔA, single dedicated stop codon.

a major producer of feed-grade vitamins A, E and D3 alongside B-group vitamins, operating large-scale fermentation infrastructure concentrated in China's vitamin-manufacturing heartland provinces.

is running a Phase 1/2a trial of AGLE-102, an MSC-derived extracellular-vesicle therapy for dystrophic epidermolysis bullosa, having dosed its first patient and reported positive initial safety data.

is developing hybrid vesicles that combine synthetic DNA constructs with vesicle-based delivery, presenting data on novel synthetic-DNA applications for cell and gene therapies at the American Society of Gene & Cell Therapy annual meeting.

founded in 1898, maintains ASTM D6866, the accelerator-mass-spectrometry radiocarbon standard that every US bio-content verification scheme (including USDA BioPreferred) relies on to physically distinguish bio-based carbon from fossil carbon.

a flagship biopharma industrial park whose tenant and partner base includes AstraZeneca, BeiGene, Innovent and other major China-based drug developers; it co-hosted the June 2026 "Future of Medicine" summit in Suzhou and continues to expand its cleanroom-equipped medical-device zone.

sells validated absolute-quantification kits — its MxP Quant 500 panel covers several hundred metabolites — run to cGMP/GLP standards, letting a lab quantify a defined metabolite panel using triple-quadrupole mass spectrometry without building its own reference library.

was one of the managing banks (alongside Barclays, Crédit Agricole, Morgan Stanley Europe and NatWest) on Italy's January 2026 dual-tranche sovereign issuance, which included a €5 billion reopening of the BTP Green bond at a 4.10% coupon under Italy's revised Green Bond Framework.

supplies Busperse 47, an 85%-biobased dispersant and penetrant used across leather processing stages from raw hide through fatliquoring, alongside Busan 1078, a dual-action bactericide for pre-soak and soak stages that controls the bacterial hide degradation that would otherwise damage hair follicles and grain quality.

has published the operative EU standard series for bio-based products — EN 16575 (terminology), EN 16785-1 (bio-content) and, effective January 2026, EN 18027:2025, which sets requirements for comparing a bio-based product's life-cycle assessment against its fossil-based equivalent.

issued a three-year, 12-billion-yuan green financial bond via the Shanghai Clearing House in March 2026 at a 1.55% rate with 3.01x subscription, taking its cumulative green financial bond issuance to 241.5 billion yuan.

its Edisto Research and Education Center runs the Carolina Strongback grafted-rootstock program, evaluating grafted watermelon nursery plants for fusarium wilt control as part of ongoing USDA-coordinated vegetable-grafting research.

announced in February 2026 that its second Phase 3 trial (COMP006) of COMP360 synthetic psilocybin met its primary endpoint in treatment-resistant depression, building on its first positive Phase 3 result.

coordinates Italy's mandatory wet-organic-fraction collection system, enforcing contamination penalties on municipalities and helping make Italy the European leader in bio-waste collection volume under the EU Waste Framework Directive.

runs an integrated multi-omics CRO offering deep central-carbon-metabolism and lipidomics panels using triple-quadrupole and Orbitrap mass spectrometry alongside capillary-electrophoresis-MS, serving both academic and industrial clients.

operating under the EU's unified European Crowdfunding Service Providers (ECSP) license, hosted a 2026 raise for Equisera, whose RiPR supercritical water-reforming technology converts biogenic and mixed waste into biomethane, hydrogen, captured CO2 and biochar.

reported positive efficacy data for its lead non-hallucinogenic psychoplastogen DLX-001 (zalsupindole) in October 2025, alongside FDA clearance of a Phase II trial design featuring at-home administration rather than clinic-based supervised dosing.

produces fermentation-derived valencene at up to 94% purity, meeting EU flavor-ingredient regulation (EU 1334/2008) requirements for use in food and beverage applications.

has developed its DeliverEX platform specifically to engineer and load exosomes with RNA payloads and gene-editing tools including CRISPR-Cas9 components for targeted delivery to difficult-to-reach tissue.

originates biotech platforms from scratch rather than investing in outside pitches — in April 2026 it launched Serif Biomedicines with an initial $50 million commitment to develop "Modified DNA" as a programmable, redosable therapeutic class, following its earlier origination of Moderna and, in 2024, Abiologics.

converts food waste into black soldier fly larvae, drying and marketing them as "Grubblies" chicken treats with roughly 50 times the calcium of mealworms, positioning BSF bioconversion as a sustainable, traceable protein source alongside its broader poultry-feed product line.

maintains the MISEV guidelines (most recently updated as MISEV2023), which set the field's minimal characterization standards for confirming vesicle identity, purity and membrane-marker profile — standards both EMA and FDA reference when evaluating EV-based product submissions.

Valencene Pure — Food-grade fermentation, Japan-approved since 2020.

pioneered the equity-free accelerator model — free shared lab space and mentorship without a forced equity stake — but confirmed in March 2026 that it is winding down its New York City site, at least the fourth JLABS location to close within the past year as J&J consolidates its incubator footprint.

supplies modular, scalable tubular PBR systems across lab-to-industrial sizes (its product line spans Lab-5 through Pilot-1100), with a documented case of its Pilot-275 unit supporting Norwegian aquaculture-feed producer CFEED's zooplankton cultivation.

produces humus de lombriz vermicompost from Eisenia fetida red worms for horticulture, gardening and nursery markets, part of Spain's position as one of Europe's largest commercial vermicompost producers.

the FDA rejected its New Drug Application for MDMA-assisted therapy for PTSD in August 2024 following an advisory committee review; the company restructured, cutting roughly 75% of its workforce, and as of a May 2026 status update remains focused on addressing the FDA's concerns rather than holding an approval.

holds patented technology (filed and granted 2024-2026) for producing oxygenated sesquiterpenes such as nootkatone and nootkatol from valencene using engineered cytochrome P450 and SrKO-class oxidase enzymes expressed in bacterial or yeast host cells.

operates its HD4 untargeted metabolomics platform alongside targeted panels (lipidomics, gut metabolites, oxidative stress), backed by a proprietary reference library, serving both discovery-stage biomarker research and pharmacometabolomic studies of drug response for pharma clients.

provides metabolomics services spanning agricultural, food and clinical applications from its Vedbæk base, part of a broader European specialization in short-chain-fatty-acid and bile-acid profiling relevant to gut-microbiome and functional-nutrition clients.

operates one of the largest municipal curbside food-waste collection systems in the country, anchored by San Francisco's mandatory organics program, feeding industrial composting facilities that convert collected food scraps and yard waste into finished compost.

the Roundtable on Sustainable Biomaterials runs a multi-stakeholder certification standard for biofuels and sustainable aviation fuel feedstock, while Germany's REDcert GmbH operates REDcert2, the chain-of-custody scheme built to comply with the EU's Renewable Energy Directive (RED II).

a global crowdfunding platform with more than 3 million investors since its 2016 founding, partnered with healthcare-focused equity-crowdfunding platform RedCrow to expand its healthcare and biotech investment offerings to retail investors.

breeds tomato rootstocks carrying Tm-1-based resistance to tomato brown rugose fruit virus (ToBRFV) and in April 2026 showcased high-resistance tomato varieties engineered to hold yield and fruit quality on par with non-resistant lines.

RSB Global Standard — Multi-stakeholder biofuel/SAF sustainability certification.

operates a cryo-electron-microscopy structural biology center (established 2018) studying G-protein-coupled receptors (GPCRs) — the receptor class serotonin 5-HT2A belongs to — providing atomic-resolution structural data that supports AI-driven design of biased, non-hallucinogenic agonists.

makes the SGM automatic grafting machine, which gained attention in Japan in 2026 after robotics distributor Iwatani selected it for an end customer and a regional trade forum featured it among the leading automatic grafters on the market.

markets chrome- and aldehyde-free tanning systems and launched Stahl Ymagine, a bio-based edge-paint range for leather matching conventional coating performance while shifting from fossil to renewable feedstock, part of its ESG Roadmap to 2030.

able to raise under the larger Regulation A+ exemption (up to $75 million) in addition to Reg CF, has hosted campaigns for Eliaz Therapeutics and Frontier Bio, a developer of lab-grown human tissue models and tissue-engineered vascular grafts intended as safer preclinical alternatives to animal studies.

showcased its sustainable leather-processing solutions, including a low-bisphenol "local for local" synthetic-tannin range, at the IILF 2026 trade show in Chennai, India, in February 2026.

a decentralized autonomous organization funding longevity research through onchain governance, has funded gene-therapy programs including Artan Bio and pursues its own dedicated Healthspan XPRIZE research plan.

hosted live 2026 Reg CF campaigns for companies including Mahzi Therapeutics (gene therapy for Pitt Hopkins Syndrome and related rare neurodevelopmental disorders) and Eliaz Therapeutics (its XGal-3 apheresis device targeting sepsis via Galectin-3 removal).

launched the Intersleek 2120 silicone foul-release coating in 2026 and joined RightShip's Zero Harm Innovation Partners Program to advance safer, cleaner marine coatings.

launched around 2022 with roughly $3 billion in funding, pursuing partial cellular reprogramming for cellular rejuvenation rather than senescent-cell clearance.

aims to provide commercial end-to-end DNA data storage solutions targeting hyperscale cloud providers and enterprise customers, competing with other emerging DNA-storage ventures.

launched by biotech firm Amyris in 2016, commercialized lab-made bio-identical squalane fermented from sugarcane-derived sucrose using engineered Saccharomyces cerevisiae, positioning "clean beauty" as scientifically rigorous rather than purely natural-marketing-driven.

manufactures polyacrylamide products for oilfield drilling, enhanced oil recovery and wastewater treatment.

has published its RENDER platform for transient delivery of programmable CRISPR epigenome editor ribonucleoproteins and holds patent filings on epigenetic-editing compositions and methods.

founded in 2018, develops the FOXO4-DRI senolytic peptide, which disrupts the FOXO4-p53 interaction to selectively trigger apoptosis in senescent cells.

working to differentiate hiPSCs — including cells reprogrammed from blood samples — into early-stage human egg cells and mini-ovary structures, aiming to eliminate the age-related fertility barrier without a donor oocyte.

has launched PYLCLARI, a PSMA-targeted 18F PET tracer for prostate cancer, commercially in Spain and Germany, extending its diagnostic-isotope logistics network across Europe.

received FDA IND clearance for EGEN-2784, its genetically engineered porcine kidney, to begin a formal clinical trial for end-stage kidney disease, building on an ongoing expanded-access compassionate-use program with reported patient updates.

has demonstrated keratin as a multifunctional, low-cost filler for industrial coatings and published research on a keratin-based 3D-printed tissue substitute for regenerative medicine.

commercializes DNA-origami-based nanorulers (the GATTA-PAINT product line) as 3D calibration standards for super-resolution (SMLM/DNA-PAINT) microscopy, and supplies DNA-origami calibrator beads used to cross-check fluorescence readout across different microscope instruments.

has extended its fermentation platform beyond conventional peptides with HumaColl™21 Select, a Type XXI collagen-based matrikine complex for topical beauty, and PrimaColl®, a vegan signaling-collagen ingredient now sold as a ready-to-drink supplement through a partnership with TOSLA.